Cronos Group Inc. (NASDAQ:CRON – Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 3,290,000 shares, a decrease of 10.6% from the December 15th total of 3,680,000 shares. Approximately 1.6% of the shares of the stock are sold short. Based on an average daily volume of 1,210,000 shares, the short-interest ratio is presently 2.7 days.
Cronos Group Stock Up 1.0 %
Shares of CRON traded up $0.02 during mid-day trading on Friday, reaching $1.99. 1,401,703 shares of the company’s stock were exchanged, compared to its average volume of 1,270,717. Cronos Group has a 52-week low of $1.86 and a 52-week high of $3.14. The company has a market cap of $760.78 million, a price-to-earnings ratio of -15.31, a PEG ratio of 1.78 and a beta of 0.97. The company has a 50-day simple moving average of $2.02 and a two-hundred day simple moving average of $2.17.
Hedge Funds Weigh In On Cronos Group
Hedge funds have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new stake in shares of Cronos Group during the third quarter valued at $37,000. Cedar Wealth Management LLC lifted its holdings in Cronos Group by 65.4% in the 2nd quarter. Cedar Wealth Management LLC now owns 37,935 shares of the company’s stock valued at $88,000 after purchasing an additional 15,000 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in Cronos Group by 119.0% in the 3rd quarter. International Assets Investment Management LLC now owns 41,643 shares of the company’s stock valued at $91,000 after purchasing an additional 22,628 shares in the last quarter. Barclays PLC acquired a new stake in shares of Cronos Group during the 3rd quarter worth about $97,000. Finally, Virtu Financial LLC grew its holdings in shares of Cronos Group by 242.7% during the third quarter. Virtu Financial LLC now owns 54,516 shares of the company’s stock worth $119,000 after buying an additional 38,607 shares in the last quarter. Hedge funds and other institutional investors own 8.71% of the company’s stock.
About Cronos Group
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Recommended Stories
- Five stocks we like better than Cronos Group
- Stock Average Calculator
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- How to Invest in Biotech Stocks
- Oilfield Leader SLB: An AI Name You Need to Know
- The How And Why of Investing in Oil Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.